^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    IMMray™ PanCan-d

    Company:
    Immunovia
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    MMray™ PanCan-d is a unique blood test for the early detection of pancreatic cancer that has the potential to dramatically increase patient survival rates: from 5-8% to up to 49%
    Cancer:
    Pancreatic Cancer
    Method:
    MicroArray